ZOETIS INC.
ZTSNYSEHealthcare · Pharmaceutical Preparations
Market cap
$32.57B
Employees
14,500
Exchange
NYSE
Headquarters
PARSIPPANY, NJ
About ZOETIS INC.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
ZTS news
ZTS Class Action Reminder - Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Zoetis Inc. Class Acton Lawsuit
GlobeNewswire Inc. · Jun 1, 2026
ZTS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Zoetis Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire Inc. · May 30, 2026
Levi & Korsinsky Announces Investigation of Securities Claims Against Zoetis (ZTS)
GlobeNewswire Inc. · May 21, 2026